Scientists at the National Institutes of Health (NIH) have created a protein that awakens resting immune cells infected with HIV and facilitates their destruction in laboratory studies. The protein potentially could contribute ...
Oct 20, 2015
0
2657
Scientists at the National Institutes of Health discovered that reactivation of ancient viral genes embedded in the human genome may cause the destruction of neurons in some forms of amyotrophic lateral sclerosis (ALS). The ...
Sep 30, 2015
5
188
Viral persistence and chronic inflammation are two key features of HIV-positive patients on antiretroviral therapy (ART). A study published on September 24th in PLOS Pathogens reports results from macaques and humans that ...
Sep 24, 2015
0
23
Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens. The research was presented at ASM's 55th Interscience Conference ...
Sep 21, 2015
0
3
Researchers have found a promising way of kicking the AIDS virus out of its hiding place in infected cells, potentially removing the main obstacle to curing HIV.
Sep 18, 2015
0
69
Researchers at Michigan State University were part of a team to discover a new natural defense against HIV infection.
Sep 16, 2015
2
960
A consortium of investigators led by scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have found that a new class of drugs may be used to purge pockets of dormant HIV from a patient's body, eliminating ...
Sep 9, 2015
0
489
(HealthDay)—Lung microbiomes are similar in patients with and without HIV, although oral microbiomes do differ significantly, according to a study published online Aug. 6 in the American Journal of Respiratory and Critical ...
Aug 26, 2015
0
5
Between one-third and one-half of individuals in the United States who were infected with HIV around the time of birth may not have sufficient immunity to ward off measles, mumps, and rubella—even though they may have been ...
Aug 13, 2015
0
16
(HealthDay)—For grass pollen-allergic HIV-positive patients treated with highly-active antiretroviral therapy (HAART), sublingual immunotherapy (SLIT) is associated with significant clinical benefits, according to a study ...
Aug 4, 2015
0
8
